1 Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Beijing, China.
2 Key Laboratory of Pharmacology of Dongzhimen Hospital (BUCM), State Administration of Traditional Chinese Medicine, Beijing, China.
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419841482. doi: 10.1177/2058738419841482.
A number of studies have shown that early-stage Alzheimer's disease (AD) is associated with abnormal brain glucose metabolism before cognitive decline, which may be the key pathological change of asymptomatic AD. The pathogenesis of AD in traditional Chinese medicine is kidney deficiency and turbid phlegm. Based on this, GAPT (a mixture of herbal extracts) was made to invigorate kidney Yang and eliminate phlegm. Previous studies have shown that GAPT can improve and delay the memory decline, but the specific therapeutic target of AD in an early stage has not been studied. The aim of this study was to investigate the effect of GAPT on glucose metabolism in the early stage of AD. Eighty-eight 3-month-old male APP/PS1 transgenic mice were randomly divided into model group; donepezil group; and low, middle and high GAPT dosage groups. Twelve 3-month-old C57BL/6J mice were used as a control group. The Morris water maze test and the Step-Down Passive-Avoidance test were used to evaluate learning and memory ability. Cerebral extraction and the accumulation of glucose were scanned with a micro-positron-emission tomography (PET) imaging system. Immunohistochemistry, western blot analysis and polymerase chain reaction (PCR) were used to detect the expression of the PI3K/AKT-mTOR signalling pathway-related proteins and messenger RNAs (mRNAs) in hippocampus of APP/PS1 transgenic mice after 3 months of drug administration. GAPT can shorten the escape latency and error numbers compared to the model group. In micro-PET imaging analysis, GAPT can increase the glucose uptake average rate in the frontal lobe, temporal lobe, parietal lobe and hippocampus. The immunohistochemistry, western blot analysis and PCR results indicated that GAPT can increase the expression of PI3K, AKT, GLUT1 and GLUT3 in the hippocampus of APP/PS1 transgenic mice. In summary, GAPT can improve brain glucose metabolism damage in APP/PS1 transgenic mice, mainly by increasing brain glucose uptake, increasing glucose transport and improving the insulin signalling pathway.
许多研究表明,在认知能力下降之前,早期阿尔茨海默病(AD)与大脑葡萄糖代谢异常有关,这可能是无症状 AD 的关键病理变化。AD 在中医中的发病机制是肾虚和痰浊。基于此,研制了 GAPT(一种草药提取物混合物)来补肾阳、化痰浊。先前的研究表明,GAPT 可以改善和延缓记忆衰退,但尚未研究 AD 早期的具体治疗靶点。本研究旨在探讨 GAPT 对 AD 早期葡萄糖代谢的影响。将 88 只 3 月龄雄性 APP/PS1 转基因小鼠随机分为模型组、多奈哌齐组、低、中、高 GAPT 剂量组。将 12 只 3 月龄 C57BL/6J 小鼠作为对照组。采用 Morris 水迷宫试验和下台阶被动回避试验评估学习记忆能力。采用微正电子发射断层扫描(PET)成像系统扫描脑葡萄糖摄取和积累。免疫组织化学、western blot 分析和聚合酶链反应(PCR)检测给药 3 个月后 APP/PS1 转基因小鼠海马中 PI3K/AKT-mTOR 信号通路相关蛋白和信使 RNA(mRNA)的表达。与模型组相比,GAPT 可缩短逃避潜伏期和错误次数。在微 PET 成像分析中,GAPT 可增加额、颞、顶叶和海马的葡萄糖摄取平均率。免疫组织化学、western blot 分析和 PCR 结果表明,GAPT 可增加 APP/PS1 转基因小鼠海马中 PI3K、AKT、GLUT1 和 GLUT3 的表达。综上所述,GAPT 可改善 APP/PS1 转基因小鼠的脑葡萄糖代谢损伤,主要通过增加脑葡萄糖摄取、增加葡萄糖转运和改善胰岛素信号通路来实现。